NSE · 28 Oct
Nifty 5022,698.85−0.22%Sensex73,246.03−0.48%Nifty Next 5067,303.70−0.06%Nifty Bank54,267.40+0.54%Nifty Fin Services24,418.25+0.47%Nifty Midcap 10057,274.70+0.43%Nifty Smallcap 10018,634.90+0.90%Nifty IT31,553.40−1.98%Nifty Auto25,707.35+1.45%Nifty FMCG42,878.35−0.56%Nifty Pharma26,541.35+1.04%Nifty Metal11,769.35−0.32%Nifty Realty797.85−0.89%India VIX16.36−0.28%Top gainersPPLPHARMA230.60+16.04%SYNGENE405.00+10.60%ZEEL69.51+7.63%TITAGARH702.00+7.52%PGEL536.40+7.16%Top losersCARTRADE2,432.00−13.80%MRPL172.90−8.73%CONCORDBIO1,265.60−7.98%TTML38.69−7.57%JUBLINGREA589.00−6.86%
Equity research

Coverage, initiations and thesis updates.

Everything we publish carries a written thesis and the three things that would make us wrong. Articles, blogs and performance reviews are free to read with an account; recommendations, which carry a buy or sell call and a target, are always premium.

ArticlesBlogsRecommendationsPerformance ReviewVideos
0 pieces

Nothing here yet

The first scored review publishes in Q2 FY28, once the earliest recommendations have had a full year to work.

Recommendations are always premium. Articles and blogs are free once you have an account.